NFKB1 and neoplasm: TLR4 signaling operates through both myeloid differentiation factor 88 (MyD88)-dependent and independent pathways, potentially promoting tumor progression by enhancing tumor cell adhesion, invasion, and metastasis via NF-κB regulation (10, 11).